Biovox provides medical‑grade bioplastics (MedEco) made from renewable polymers such as bio‑PE, PLA and PEF that meet ISO 13485, VDI 2017 and ISO 10993 standards, ensuring patient safety and compliance with critical‑substance regulations. The materials are compatible with injection molding, extrusion and film processes, can be supplied in standard or custom formulations, and enable up to 85 % CO₂ reduction with full mechanical and chemical recyclability. By offering consistent supply, technical consulting and regulatory support, Biovox helps medical‑device, pharma packaging and laboratory equipment manufacturers adopt sustainable, high‑performance polymer solutions.
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
4OHHFounders
Product
Problem
Medical device and pharmaceutical manufacturers face increasing regulatory pressure and sustainability requirements, yet many available plastics contain hazardous substances and rely on fossil‑based feedstocks, limiting patient safety and environmental performance.
Solution
Biovox supplies medical‑grade bioplastics—its MedEco line—designed specifically for the health‑care sector. The company offers bio‑based polymers such as bio‑PE, PLA and PEF that meet ISO 13485, VDI 2017 and ISO 10993 standards, ensuring high patient safety without critical substances like PFAS, BPA or phthalates. These materials are engineered for common processing methods (injection molding, extrusion, film and tubing) and can be provided in standard grades or customized formulations. By using renewable feedstocks and enabling full mechanical and chemical recycling, Biovox helps customers reduce CO₂ emissions by up to 85 % and lower dependence on fossil resources, while maintaining consistent supply and performance.
Target Audience
Primary customers are medical‑device manufacturers, pharmaceutical packaging producers, and laboratory equipment suppliers seeking compliant, sustainable polymer solutions.
Features
- Bio‑based polymer portfolio (bio‑PE, PLA, PEF) certified for medical use under ISO 13485 and VDI 2017
- Proven biocompatibility (ISO 10993) and free of PFAS, BPA, phthalates for critical substance compliance
- Compatibility with injection molding, profile, tubing and film extrusion processes
- Up to 85 % CO₂ reduction (cradle‑to‑grave) and full mechanical/chemical recyclability
- Guaranteed material consistency and supply continuity for regulated environments
- Technical consulting on material selection, regulatory documentation and sustainability reporting